{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 7804, "pageSize": 30, "pageCount": 10666, "rows": [ { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a color-coded sidebar on the right to categorize the drug's development stage (Oncology).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/30", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-30", "loopMatches": [ { "to": 40, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "dffbb50c-e367-4fbd-9f65-f687fdc06626", "evidence": "Discussion of AstraZeneca's scientific approach and goals", "position": 1, "objective": "Explaining the 'why' behind AstraZeneca's pipeline and portfolio", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide provides a structured overview of five specific clinical trials (TROPION-Breast01 through 05).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/31", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-31", "loopMatches": [ { "to": 40, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "dffbb50c-e367-4fbd-9f65-f687fdc06626", "evidence": "Discussion of AstraZeneca's scientific approach and goals", "position": 1, "objective": "Explaining the 'why' behind AstraZeneca's pipeline and portfolio", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is part of an appendix, indicated by the footer and the 'Appendix' label.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/32", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-32", "loopMatches": [ { "to": 40, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "dffbb50c-e367-4fbd-9f65-f687fdc06626", "evidence": "Discussion of AstraZeneca's scientific approach and goals", "position": 1, "objective": "Explaining the 'why' behind AstraZeneca's pipeline and portfolio", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "appendix_data", "function": "appendix", "notes": "The slide is part of an appendix, specifically detailing late-stage development assets in Oncology.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/33", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-33", "loopMatches": [ { "to": 40, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "dffbb50c-e367-4fbd-9f65-f687fdc06626", "evidence": "Discussion of AstraZeneca's scientific approach and goals", "position": 1, "objective": "Explaining the 'why' behind AstraZeneca's pipeline and portfolio", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is part of an appendix, indicated by the page number 34 and the 'Appendix: Glossary' link at the bottom.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/34", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-34", "loopMatches": [ { "to": 40, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "dffbb50c-e367-4fbd-9f65-f687fdc06626", "evidence": "Discussion of AstraZeneca's scientific approach and goals", "position": 1, "objective": "Explaining the 'why' behind AstraZeneca's pipeline and portfolio", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is part of an appendix section, indicated by the page number and glossary link.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/35", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-35", "loopMatches": [ { "to": 40, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "dffbb50c-e367-4fbd-9f65-f687fdc06626", "evidence": "Discussion of AstraZeneca's scientific approach and goals", "position": 1, "objective": "Explaining the 'why' behind AstraZeneca's pipeline and portfolio", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is part of an appendix, detailing specific trial designs, patient counts, and status for TROPION-PanTumor trials.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/36", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-36", "loopMatches": [ { "to": 40, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "dffbb50c-e367-4fbd-9f65-f687fdc06626", "evidence": "Discussion of AstraZeneca's scientific approach and goals", "position": 1, "objective": "Explaining the 'why' behind AstraZeneca's pipeline and portfolio", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a vertical navigation bar on the right to indicate the drug's development stage (Late-stage development) and therapeutic area (Oncology).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/37", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-37", "loopMatches": [ { "to": 40, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "dffbb50c-e367-4fbd-9f65-f687fdc06626", "evidence": "Discussion of AstraZeneca's scientific approach and goals", "position": 1, "objective": "Explaining the 'why' behind AstraZeneca's pipeline and portfolio", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes trial identifiers (NCT numbers) and status timelines.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/38", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-38", "loopMatches": [ { "to": 40, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "dffbb50c-e367-4fbd-9f65-f687fdc06626", "evidence": "Discussion of AstraZeneca's scientific approach and goals", "position": 1, "objective": "Explaining the 'why' behind AstraZeneca's pipeline and portfolio", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is an appendix page detailing clinical trial pipeline data for a specific drug.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/39", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-39", "loopMatches": [ { "to": 40, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "dffbb50c-e367-4fbd-9f65-f687fdc06626", "evidence": "Discussion of AstraZeneca's scientific approach and goals", "position": 1, "objective": "Explaining the 'why' behind AstraZeneca's pipeline and portfolio", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 40, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table lists five distinct clinical trials (SERENA-2, SERENA-3, NCT04541433, SERENA-1, NCT04818632).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/40", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-40", "loopMatches": [ { "to": 40, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "dffbb50c-e367-4fbd-9f65-f687fdc06626", "evidence": "Discussion of AstraZeneca's scientific approach and goals", "position": 1, "objective": "Explaining the 'why' behind AstraZeneca's pipeline and portfolio", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 41, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is part of an appendix section detailing clinical trial pipelines.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/41", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-41", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 42, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is part of an appendix, specifically detailing late-stage development assets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/42", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-42", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 43, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is part of an appendix, providing detailed clinical trial data for a specific asset.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/43", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-43", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 44, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide provides a structured overview of four specific clinical trials (EvoPAR-Prostate01, EvoPAR-Breast01, PETRA, PETRANHA).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/44", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-44", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 45, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is part of an appendix, providing specific clinical trial data for a drug candidate.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/45", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-45", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 46, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is an appendix page detailing the clinical development pipeline for a specific drug candidate.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/46", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-46", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 47, "slideType": "appendix_data", "function": "analyze_data", "notes": "Slide 47 of a presentation deck.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/47", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-47", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 48, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/48", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-48", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 49, "slideType": "appendix_data", "function": "analyze_data", "notes": "Slide 49 of a presentation deck.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/49", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-49", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 50, "slideType": "appendix_data", "function": "analyze_data", "notes": "Part of a pipeline appendix deck.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/50", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-50", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 51, "slideType": "appendix_data", "function": "analyze_data", "notes": "Slide 51 of a presentation deck.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/51", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-51", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 52, "slideType": "appendix_data", "function": "analyze_data", "notes": "Part of a larger portfolio deck, indicated by the vertical navigation bar on the right.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/52", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-52", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 53, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is part of an appendix, providing detailed clinical trial data for a specific drug candidate.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/53", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-53", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 54, "slideType": "appendix_data", "function": "analyze_data", "notes": "Slide 54 of a larger deck, part of the appendix.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/54", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-54", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 55, "slideType": "appendix_data", "function": "analyze_data", "notes": "Slide 55 of a presentation deck.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/55", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-55", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 56, "slideType": "appendix_data", "function": "analyze_data", "notes": "Part of a clinical pipeline appendix.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/56", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-56", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 57, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide provides a summary of two clinical trials (PRIMROSE and PRIMAVERA) including population, patient counts, design, endpoints, and status.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/57", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-57", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 58, "slideType": "appendix_data", "function": "analyze_data", "notes": "Part of a corporate presentation appendix, specifically under the Oncology pipeline section.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/58", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-58", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 59, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a standard clinical trial table format common in pharmaceutical investor presentations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/59", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-59", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }